Acute pulmonary pressure change after transition to sacubitril/valsartan in patients with heart failure reduced ejection fraction

AIMS: Sacubitril/valsartan combines renin–angiotensin–aldosterone system inhibition with amplification of natriuretic peptides. In addition to well‐described effects, natriuretic peptides exert direct effects on pulmonary vasculature. The effect of sacubitril/valsartan on pulmonary artery pressure (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Jeffrey S., Havakuk, Ofer, McLeod, Jennifer M., Hwang, Jennifer, Kwong, Hoi Yan, Shavelle, David, Zile, Michael R., Elkayam, Uri, Fong, Michael W., Grazette, Luanda P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006690/
https://www.ncbi.nlm.nih.gov/pubmed/33522140
http://dx.doi.org/10.1002/ehf2.13225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006690/
https://www.ncbi.nlm.nih.gov/pubmed/33522140
http://dx.doi.org/10.1002/ehf2.13225

Ejemplares similares